Doctor profile · Federal record

Dr. Mark Routbort, M.D., PHD

Hematology (Pathology) Physician (CMS: Pathology) · Houston, TX

  • NPI 1699849133
  • Accepts Medicare
  • MIPS 79.4 / 100 · 2023
  • 27 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1515 Holcombe Blvd
Houston, TX 770304009
(713) 792-6161
Mailing address
Po Box 4439
Houston, TX 772104439

Credentials & registration

NPPES · NUCC
NPI registered
November 2006 — 20 yrs on file
Profile last updated
July 6, 2012
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207ZH0000X — NUCC code
State license (1)
Texas #L8930
Medicaid
TX #166115901

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1699849133. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,604
Distinct HCPCS
1
Medicare allowed
$75,455
HCPCS Description Services Patients Avg allowed
G0452 Molecular pathology procedure; physician interpretation and report 1,604 907 $47

In context: peer comparison

Among 13 peers in Houston Hematology (Pathology) Physician, average services per provider: 179. This provider delivers 9.0× the peer median.

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Routbort's medical specialty?
Dr. Mark Routbort practices Hematology (Pathology) Physician in Houston, TX.
Where does Dr. Mark Routbort practice?
Dr. Mark Routbort practices at 1515 Holcombe Blvd, Houston, TX 770304009. Office phone: 7137926161.
What is Dr. Mark Routbort's NPI?
Dr. Mark Routbort's National Provider Identifier (NPI) is 1699849133, issued by NPPES.
Does Dr. Mark Routbort accept Medicare assignment?
Yes. Dr. Mark Routbort accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Routbort commonly perform?
Top Medicare-reported procedures in 2023: Molecular pathology procedure; physician interpretation and report (HCPCS G0452). Source: CMS Medicare Physician & Other Practitioners file.